Inventor · disambiguated record
David Morrissey
Also filed as: MORRISSEY DAVID · MORRISSEY DAVID V
10 granted patents·30 pending applications·301 citations·filing 1992–2024
91Inventor score
Files withSIRNA THERAPEUTICS INC20INTELLIA THERAPEUTICS INC5AMOCO CORP3JADHAV VASANT1MERCK SHARP & DOHME1
Top patents by PatentIndex Score
40 records- 0194US6268128B1Immobilized oligonucleotide probes and uses thereofVYSIS INC·Filed 1992·Granted Jul 31, 2001·104 cites·33 claims
- 0293US11479767B2Modified guide RNAsINTELLIA THERAPEUTICS INC·Filed 2019·Granted Oct 25, 2022·12 cites·27 claims
- 0392US7935812B2RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)MERCK SHARP & DOHME·Filed 2009·Granted May 3, 2011·28 cites·13 claims
- 0492US7517864B2RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2005·Granted Apr 14, 2009·16 cites·16 claims
- 0585US2025059532A1Modified Guide RNAsINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0679US12173284B2Modified guide RNAsINTELLIA THERAPEUTICS INC·Filed 2022·Granted Dec 24, 2024·0 cites·31 claims
- 0778US5759777AHybridization promotion reagentsAMOCO CORP·Filed 1995·Granted Jun 2, 1998·61 cites·11 claims
- 0873US8945904B2Influenza virus reassortmentTRUSHEIM HEIDI·Filed 2011·Granted Feb 3, 2015·2 cites·28 claims
- 0970US2006292691A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1070US2007004667A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1168US5457025AMethods and compositions for preventing interference with affinity capture schemesAMOCO CORP·Filed 1992·Granted Oct 10, 1995·43 cites·6 claims
- 1268US2006247429A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1368US2006287266A1RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1468US2006217336A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1567US5589335AHybridization promotion reagentsAMOCO CORP·Filed 1994·Granted Dec 31, 1996·35 cites·12 claims
- 1666US9574181B2Influenza virus reassortment methodSEQIRUS UK LTD·Filed 2014·Granted Feb 21, 2017·0 cites·10 claims
- 1766US2023203480A1Lipid nanoparticle formulations for crispr/cas componentsINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1865US2006281175A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1965US2006275903A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2063US2006217337A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2163US2006247428A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2263US2006217335A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2363US2006217334A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2456US2009176725A1Chemically modified short interfering nucleic acid molecules that mediate rna interferenceSIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2553US2008207542A1RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2652US2021349061A1Liquid chromatography based detection and quantitation of phospho prodrugs and their active metabolitesWATERS TECHNOLOGIES CORP·Filed 2021·Application pending·0 cites
- 2752US2015105445A1RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2851US2005209182A1Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activitySIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2950US2007032441A1Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3050US2005032733A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3149US2004054156A1Method and reagent for inhibiting hepatitis B viral replicationFiled 2003·Application pending·0 cites
- 3248US2003206887A1RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)Filed 2002·Application pending·0 cites
- 3347US2004127446A1Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replicationFiled 2003·Application pending·0 cites
- 3445US2006217331A1Chemically modified double stranded nucleic acid molecules that mediate RNA interferenceSIRNA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 3544US2010015218A1Compositions and methods for potentiated activity of biologically active moleculesJADHAV VASANT·Filed 2008·Application pending·0 cites
- 3644US2003068301A1Method and reagent for inhibiting hepatitis B virus replicationFiled 2001·Application pending·0 cites
- 3743US2002001811A1Immobilized oligonucleotide probes and uses thereforFiled 2001·Application pending·0 cites
- 3843US2003148985A1Methods and reagents for the inhibition of hepatitis B virus replicationFiled 2002·Application pending·0 cites
- 3942US2019136231A1Lipid nanoparticle formulations for crispr/cas componentsINTELLIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4041US2006211642A1RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Morrissey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →